Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE, April 13, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived live tumor…
WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) — We are developing the infrastructure of a global zoonotic infectious diseases “alert…
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies…
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential…
– Appointment strengthens leadership team as the Company readies for potential global odevixibat launch and progresses multiple clinical development programs…
Phase 1b/2a Study Expected to Begin In 2Q 2021DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc.…
– Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational…
Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK Reported Positive Pre-Clinical Data Associated with…
– Ongoing ADAIR SEAL study on target for pivotal data readout in second half of 2021- Target NDA filing in…
Study meets primary safety endpoint; positive secondary efficacy assessments support potential benefit from Lomecel-B Decline in cognitive function slower in…